- Home
- NFBK vs BVS Comparison
NFBK vs BVS Comparison
Compare NFBK & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFBK
- BVS
- Stock Information
- Founded
- NFBK 1887
- BVS 2011
- Country
- NFBK United States
- BVS United States
- Employees
- NFBK N/A
- BVS N/A
- Industry
- NFBK Major Banks
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NFBK Finance
- BVS Health Care
- Exchange
- NFBK Nasdaq
- BVS Nasdaq
- Market Cap
- NFBK 454.5M
- BVS 476.3M
- IPO Year
- NFBK 2007
- BVS 2021
- Fundamental
- Price
- NFBK $10.00
- BVS $7.46
- Analyst Decision
- NFBK Hold
- BVS Strong Buy
- Analyst Count
- NFBK 3
- BVS 4
- Target Price
- NFBK $12.67
- BVS $13.75
- AVG Volume (30 Days)
- NFBK 192.0K
- BVS 289.9K
- Earning Date
- NFBK 10-22-2025
- BVS 11-04-2025
- Dividend Yield
- NFBK 5.08%
- BVS N/A
- EPS Growth
- NFBK 51.92
- BVS N/A
- EPS
- NFBK 0.97
- BVS 0.15
- Revenue
- NFBK $141,983,000.00
- BVS $563,829,000.00
- Revenue This Year
- NFBK $9.42
- BVS N/A
- Revenue Next Year
- NFBK $7.14
- BVS $7.22
- P/E Ratio
- NFBK $10.53
- BVS $48.05
- Revenue Growth
- NFBK 13.99
- BVS 1.58
- 52 Week Low
- NFBK $9.40
- BVS $5.81
- 52 Week High
- NFBK $14.39
- BVS $12.61
- Technical
- Relative Strength Index (RSI)
- NFBK 32.36
- BVS 60.56
- Support Level
- NFBK $10.00
- BVS $6.50
- Resistance Level
- NFBK $10.25
- BVS $8.23
- Average True Range (ATR)
- NFBK 0.29
- BVS 0.34
- MACD
- NFBK -0.05
- BVS 0.07
- Stochastic Oscillator
- NFBK 1.97
- BVS 55.78
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.